72. Fields B. S., Benson R. S., Besser R. E. (2002), “Legionella and Legionnaires' Disease: 25 Years of Investigation”, Clin Microbiol Rev, July; 15(3), pp. 506–526.
73. Fiumefreddo R., Zaborsky R., Haeuptle J. (2009), “Clinical predictors for Legionella in patients presenting with community- acquired pneumonia to the emergency department”, BMC Pulm Med. 9, pp. 4.
74. Forest W. A, Summersgill J. T. et al (2007), “A Worldwide Perspective of Atypical Pathogens in Community-acquired Pneumonia”. American Journal of Respiratory and Critical Care Medicine, Vol 17, pp. 1086-1093.
75. Foy H. M. (1991), Manual of clinical microbiology, Vol II, Cheapter 21, PP. 434 – 465.
76. Foy H. M. (1993), “ Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients”, Clin Infect Dis, 17, pp. 37 -46.
77. Foy H. M., Kenny G. E., Cooney M. K., Allan I. D. (1979), “Long- Term Epidemiology of Infections with Mycoplasma pneumoniae”, The Journal of infectious diseases. june Vol. 139, (6).
78. Fraser D. W., Tsai T. R., Orenstein W. et al (1977), “Legionnaires' disease: description of an epidemic of pneumonia”, N. Engl. J. Med. 297, pp. 1189-1197.
79. Friedman H., Yamamoto Y., Klein T. W. (1980), “Legionella pneumophila pathogenesis and immunity”, Seminars in Pediatric Infectious Diseases, Volume 13, Issue 4, pp.273-279.
80. Gacouin A.,Tulzo Y. L., Lavoue S., Camus C. et al (2002), “Severe pneumonia due to Legionella pneumophila: prognostic factors, impact of delayed appropriate antimicrobial therapy”, Intensive Care Med, 28: pp.686–691.
81. Garduđo R. A. (2007), “ Life cycle, growth cycles and developmental cycle of Legionella pneumophila”, Infectious Agents and Pathogenesis, 2007, pp. 65-84.
82. Gerald W., Fernald M. D. (1983), “Immunologic Mechanisms Suggested in the Association of M.pneumoniae Infection and Extrapulmonary Disease:Areview”, The Yale journal of biology and medicine 56, pp. 475-479.
83. Glick T. H., Gregg M. B., Berman B., Mallison G. (1978), “Pontiac fever. An epidemic of unknown etiology in a health department. I. Clinical and epidemiologic aspects”, Am. J. Epidemiol. 107, pp. 149-160.
84. Grayston JT (2000), “ Background and current knowledge of Chlamydia pneumoniae and atherosclerosis”, J Infect Dis 181 Suppl 3: pp 402-10.
85. Grayston J. T., Aldous M. B., Easton A. at al (1993), “Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis”, J Infect Dis , 168, pp. 1231 –1235.
86. Grayston J. T., Campbell L. A., Kuo C. C. (1990), “A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR”, J Infect Dis, 161, pp. 618–625.
87. Grayston J. T., Kuo C. C., Campbell L. A. at al (1989), “Chlamydia pneumoniae sp. nov. for Chlamydia sp. strain TWAR”, Int. J. Syst. Bacteriol, 39, pp. 88–90.
88. Grayston J. T., Kuo C. C., Wang S. P., Altman J. (1986), “A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infection”, N. Engl. J. Med. 315, pp. 161–168.
89. Greenberg D., Chiou C. C., Famigilleti R. (2006), “Problem pathogens: paediatric legionellosis—implications for improved diagnosis”, Lancet Infect Dis, 6, pp. 529–35.
90. Gutiérrez F., Masiá M., Rodríguez J. C., Mirete C., Soldán B. et al (2005), “Community-acquired pneumonia of mixed etiology: prevalence, clinical characteristics, and outcome”, Eur J Clin Microbiol Infect Dis. Jun; 24(6), pp. 377-83.
91. Hammerscblag A. R. (1996), “Clamydia”, Nellson’Textbook of pediatrics, volum 1, chepter 196, pp 827- 831.
92. Hammerschlag M. R. (2003), “Pneumonia due to Chlamydia pneumoniae in children: epidemiology, diagnosis, and treatment”, Pediatr Pulmonol, Nov, 36(5), pp. 384-90.
93. Hammerschlag M. R. (2003), “Pneumonia due to Chlamydia pneumoniae in Children: Epidemiology, Diagnosis, and Treatment”, Pediatric Pulmonology 36, pp. 384–390.
94. Hassan M., Faiz N. (2009), “Atypical Pneumonia in Children in Islamabad: Clinical Features And Response to Macrolides”, Ann. Pak. Inst. Med. Sci. 5(2), pp. 70-73.
95. Hauksdottir G. S., Sigurdardottir V., Jonsson T. (1999), “Outbreaks of Mycoplasma pneumoniae infections in Iceland 1987 to 1997: a ten and a half years review”, Eur. J. Epidemiol 15(1), pp. 95-96.
96. Heath C. H., Grove D. I., Looke D. F. (1996), “Delay in appropriate therapy of Legionella pneumonia associated with increased mortality.”, Eur J Clin Microbiol Infect Dis.Apr, 15(4), pp. 286-290.
97. Heiskanen-Kosma T., Korppi M. et al (1999), “Chlamydia pneumoniae is an Important Cause of Community-acquired Pneumonia in School-aged Children: Serological Results of a Prospective, Population-based Study”, Scand J Infect Dis 31, pp. 255–259.
98. Herrmann B., Salih M. A. M., Yousif B. E. at al (1994), “Chlamydial etiology of acute lower respiratory tract infections in children in the Sudan”, Acta Paediatr, 83, pp. 169–72.
99. Himmelreich R., Hilbert H., Plagens H. (1996), Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae”, Nucleic Acids Res.24, pp. 4420-4449.
100. Hoek J. V. D, Levin M. D.,Valk P. V. D (2008), “Severe autoimmune haemolytic anaemia in two patients: remember Mycoplasma pneumoniae infection”, Neth j crit care volume 12, (4), august 2008.
101. Holmberg R. E., Pavia A. T., Montgomery D. (1993), “Nosocomial
Legionella pneumonia in the neonate”, Pediatrics 2(3), pp. 450-453.
102. Hong S. J. (2012), “The Role of Mycoplasma pneumoniae Infection in Asthma”, Allergy Asthma Immunol Res, March; 4(2), pp. 59 – 61.
103. Hsieh C. C., Tang R. B., Tsai C. H., Chen W. (2001), “Serum interleukin-6 and tumor necrosis factor-alpha concentrations in children
with Mycoplasma pneumoniae”, Microbiol Immunol | Infect, 34, pp. | |
104. | 109- 12. Hsieh S. C., Kuo Y. T., Chern M. S. (2007), | “Mycoplasma |
pneumonia: Clinical and radiographic features in | 39 children”, | |
105. | Pediatrics International, Vol 49, Issue 3, pp. 363–367. Hsu C. M. , Huang L. M., Kao Y. F. (1996), | “Prevalence of |
Có thể bạn quan tâm!
-
Một Số Yếu Tố Liên Quan Của Viêm Phổi Không Điển Hình Nặng -
Về Thời Gian Bị Bệnh Và Kháng Sinh Điều Trị Trước Vào Viện -
Phạm Thu Hiền, Đào Minh Tuấn, Nguyễn Phong Lan, Phan Lê Thanh Hương -
Rockey D. D., Lenart J., Stephens R. S. (2000), “Genome Sequencing And Our Understanding Of Chlamydiae”, Infect Immun, 68, Pp. 5473 –5479. -
Nghiên cứu một số đặc điểm dịch tễ học, lâm sàng viêm phổi không điển hình do vi khuẩn ở trẻ em - 20 -
Nghiên cứu một số đặc điểm dịch tễ học, lâm sàng viêm phổi không điển hình do vi khuẩn ở trẻ em - 21
Xem toàn bộ 182 trang tài liệu này.
Legionella pneumophila infection in children and its role in pediatric community-acquired atypical pneumonia”, Acta. Paed. Sing, 37(3), pp. 188-192.
106. Huong P. L. T, Thi L. T., Sasaki T. et al (2007), “First report on clinical features of Mycoplasma pneumoniae infections in Vietnamese children”, Jpn.J. Infec.Dis, (60), pp. 370 -373.
107. Husain M. H., Abdulrahman H. I., Abdulqader B. (2004), “Mycoplasma Pneumonia Associated with Severe Autoimmune Hemolytic Anemia”, Kuwait Medical Journal, 36 (2), pp. 131-133.
108. Hyman C. L., Roblin P. M., Gaydos C. A., Quinn T. C. at al (1995), “Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture”, Clin Infect Dis,20, pp. 1174–1178.
109. Ian C., Michelow M. D., Kathy Katz B. S., George H. (2007), “Systemic Cytokine Profile in Children With Community-Acquired Pneumonia”, Pediatric Pulmonology 42, pp. 640–645 (2007).
110. Ian C., Olsen K., Lozano J. et al (2004), “Epidemiology and Clinical Characteristics of Community-Acquired Pneumonia in Hospitalized Children”, Pediatrics Vol. 113 No. 4 April, pp.701 -707.
111. Iwańczak F., Stawarski A., Iwańczak B., Choroszy-Król I. et al (2001), “Evaluation of an atypical clinical presentation for pneumonia caused by Mycoplasma pneumoniae and Chlamydia sp in children”, Wiad Lek, 54(1-2), pp. 26-37.
112. Jepras R. I., Fitzgeorge R. B., Baskerville A. (1985), “A comparison of virulence of two strains of Legionella pneumophila based on experimental aerosol infection of guinea-pigs”, J. Hyg. (Lond.) 95, pp. 29-38.
113. Johnston S. L., Martin R. J. (2005), “Chlamydophila pneumoniae and Mycoplasma pneumoniae A Role in Asthma Pathogenesis?”, American Journal of Respiratory and Critical Care Medicine Vol 172. pp. 1078-1089.
114. Joseph C. A., Kicketts K. D. (2010), “Legionnaires diseases”,
Eurosurveillance, Volume 15, Issue 8, 25 February 2010.
115. Kashyap S., Sarkar M. (2010),“Mycoplasma pneumonia: Clinical features and management”, Lung India, vol 27, Issue 2, Apr Jun.
116. Kassha K., Abuanza I., Hadi S. A. et al (2009), “Severe Legionnaires disease complicated by multi-organ dysfunction in a previously healthy patient: a case report”, Cases Journal, 2, pp. 9151.
117. Katz S. M., Hammel J. M. (1987). “The effect of drying, heat, andp Hon the survival of Legionella pneumophila”, Ann Clin Lab Sci17(3): pp.150–6.
118. Kenny G. E. (1991), Manual of clinical microbiology, Cheapter 47, pp. 478 – 482.
119. Kicinski P., Wisniewska-Ligier M., Wozniakowska-Gesicka T. (2011), “Pneumonia caused by Mycoplasma pneumoniae and Chlamydophila pneumoniae in children - comparative analysis of clinical picture”, Adv Med Sci, Jun 1, 56(1), pp. 56-63.
120. Kim C., Nyoka R., Jamal A. (2011), “Epidemiology of Respiratory Infections Caused by Atypical Bacteria in Two Kenyan Refugee Camps”, J Immigrant Minority Health, published online 24 june 2011.
121. Klement E., Talkington D. F., Asserzug O., Kayouf R. (2005), “Identification of Risk Factors for Infection in an Outbreak of Mycoplasma pneumoniae”, Respiratory Tract Disease, Oxford Journals Medicine Clinical Infectious Diseases Volume 43, Issue10, pp. 1239-1245.
122. Klieneberger E. (1935), “The natural occurrence of pleuropneumonia- like organisms in apparent symbiosis with Streptobacillus moniliformis and other bacteria”, J. Pathol. Bacteriol. 40, pp. 93–105
123. Krivan H. C., Olsonll L. D. et al (1989), “Adhesion of Mycoplasma pneumoniae to Sulfated Glycolipids and Inhibition by DextranSulfate”.The journal of biological chemistry, Val. 264, No. 16, Issue of June 5, pp.9283-9288.
124. Kuo C. C, Jackson L. A., Grayston J. I., Ampbell A. (1995), “Chlamydia pneumoniae (TWAR)”, Clinical microbiology reviews, Oct. Vol. 8, (4), pp. 451–461.
125. Kurz H. , Göpfrich H., Wabnegger L., Apfalter P. (2009), “ Role of Chlamydophila pneumoniae in children hospitalized for community- acquired pneumonia in Vienna, Austria”, Pediatr Pulmonol. Sep;44(9), pp. 873-6.
126. Lee K. Y., Youn Y. S., Lee J. W., Kang J. H. (2010), “Mycoplasma pneumoniae pneumonia, bacterial pneumonia and viral pneumonia”, Jornal de Pediatria - Vol. 86, No. 6, 2010.
127. Leggiadro, Robert J. (2009), “Community Outbreak of Mycoplasma pneumoniae Infection: School-Based Cluster of Neurologic Disease Associated With Household Transmission of Respiratory Illness”, Pediatric Infectious Disease Journal: March, Volume 28, Issue 3, pp. 260.
128. Lenglet A., Herrador Z., Magiorakos A. P., Leitmeyer K. et al (2012), “Surveillance status and recent data for Mycoplasma pneumoniae infections in the European Union and European Economic Area”, Eurosurveillance, vol 17, weekly isure 5, January 2012.
129. Lieberman D., Livnat S., Schlaeffer F., Porath A., Horowitz S. (1997), “IL-1beta and IL-6 in community-acquired pneumonia: bacteremic pneumococcal pneumonia versus Mycoplasma pneumoniae pneumonia”, Infection 1997, 25, pp. 90–4.
130. Lind K., Benzon M. W., Jensen J. S. et al (1997), “A seroepidemiological study of Mycoplasma pneumoniae infections in Denmark over the 50-year period 1946-1995”, Eur. J. Epidemiol. 13(5), pp. 581-586.
131. Linz D. H., Tolle S. W., Elliot D. L. (1994), “Mycoplasma pneumoniae pneumonia: experience at a referral center”, West J Med, 140, pp. 895–900.
132. Liu C., Eaton M. D., Heyl J. T. (1957), “Studies on atypical pneumonia. II. Observations concerning the development and immunological characteristics of antibody in patients”, J. Exp. Med, 109, pp. 545.
133. Lochindarat S., Suwanjutha S., Prapphal N., et al (2007), “Mycoplasma pneumoniae and Chlamydophila pneumoniae in children with community-acquired pneumonia in Thailand”, Int J Tuberc Lung Dis. Jul;11(7), pp.814-9.
134. Lucier T. S., Heitzman K., Liu S. K., Hu P. C. (1995), “Transition mutations in the 23S rRNA of erythromycin- resistant isolates of Mycoplasma pneumoniae”, Antimicrob Agents chemother, 39, pp. 2770-2773.
135. Lung D. C, Chan Y. H., Kwong L., Que T. L. (2006), “Severe community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in a 6-year-old boy”, Hong Kong Med J, Vol 17 N o 5, October 2011.
136. Ma L.D., Chen B., Dong Y., Fan J., Xia L., Wang S. Z., Liu Q., Jiang
L. (2010), “Rapid mycoplasma culture for the early diagnosis of
Mycoplasma pneumoniae infection”, J Clin Lab Anal. 24(4), pp. 224-9.
137. Madani T.A. Al-Ghamdi A. A. (2001), “Clinical features of culture- proven Mycoplasma pneumoniae infections at King Abdulaziz University Hospital, Jeddah, Saudi Arabia”. BMC Infect Dis. 1, pp. 6.
138. Maheshwari M., Kumar S., Sethi G. R., Bhalla P. (2002), “Detection of Mycoplasma pneumoniae in children with lower respiratory tract infections”, Trop Doct. Jan;41(1), pp. 40-2.
139. Maltezou H. C. et al (2004), “Mycoplasma pneumoniae and Legionella pneumophila in community-acquired lower respiratory”, Scand J Infect Dis 36, pp. 639-42.
140. Marmion B. P., Goodburn G. M., (1961), “Effect of an inorganic gold salt on Eaton's primary atypical pneumonia agent and other observations”, Nature 189:247-248,in Ken B. Waites, Deborah F, Talkington (2004), “Mycoplasma pneumoniae and Its Role as a Human Pathogen”, Clin Microbiol Rev. October; 17(4), pp. 697–728.
141. Marston B. J., Lipman H. B. et al. (1994). “Surveillance for Legionnaires’ disease. Risk factors for morbidity and mortality”, Arch Intern Med 154 (21), pp. 2417–22.